Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report

被引:23
|
作者
Wang, Yubao [1 ]
Speeg, Kermit V. [2 ]
Washburn, William Kenneth [2 ]
Half, Glenn [2 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Transplant Ctr, San Antonio, TX 78229 USA
关键词
Hepatocellular carcinoma; Liver transplantation; Mammalian target of rapamycin inhibitor; Sirolimus; Sorafenib; RENAL-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; MAMMALIAN TARGET; THERAPY; EXPERIENCE; INHIBITOR; PATHWAY; GROWTH; MODELS;
D O I
10.3748/wjg.v16.i43.5518
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A case of hepatocellular carcinoma (HCC) with pulmonary recurrence after liver transplantation for HCC is presented in this report. The patient showed disease progression on sorafenib therapy demonstrated by computed tomography scans as well as serial serum a-fetoprotein (AFP) elevation. After his immunosuppression therapy was successfully transitioned to sirolimus and a continuation of sorafenib, he achieved partial remission based on RECIST criteria and normalization of AFP. Mammalian target of rapamycin inhibitors including sirolimus alone or in conjunction with sorafenib may be useful in the treatment of post transplant HCC. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:5518 / 5522
页数:5
相关论文
共 50 条
  • [1] Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report
    Kermit V Speeg
    William Kenneth Washburn
    Glenn Halff
    [J]. World Journal of Gastroenterology, 2010, 16 (43) : 5518 - 5522
  • [2] BENEFIT OF TREATING HCC RECURRENCE AFTER LIVER TRANSPLANTATION
    Sapisochin, Gonzalo
    Astete, Santiago
    Dopazo, Cristina
    Castells, Luis
    Bilbao, Itxarone
    Lazaro, Jose L.
    Minguez, Beatriz
    Caralt, Mireia
    Charco, Ramon
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 40 - 40
  • [3] DOES LATE RECURRENCE AFTER HEPATECTOMY FOR HCC IMPACT ON SURVIVAL AFTER LIVER TRANSPLANTATION FOR HCC RECURRENCE? A CASE REPORT
    Sapisochin, Gonzalo
    Dopazo, Cristina
    Rodriguez, Roberto
    Espin, Francesc
    Castells, Luis
    Caralt, Mireia
    Lazaro, Jose Luis
    Bilbao, Itxarone
    Charco, Ramon
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 238 - 238
  • [4] Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue
    Mancuso, Andrea
    Mazzarelli, Chiara
    Perricone, Giovanni
    Zavaglia, Claudio
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (03) : 681 - 681
  • [5] Reply to: "Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue"
    Sposito, Carlo
    Mazzaferro, Vincenzo
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (03) : 682 - 683
  • [6] A Case of Late Recurrence of HCC after Living Donor Liver Transplantation
    Lim, Tae-Wan
    Park, Pyoung-Jae
    Choi, Sae Byeol
    Kim, Wan Bae
    Choi, Sang Yong
    [J]. TRANSPLANTATION, 2016, 100 : S257 - S257
  • [7] EVEROLIMUS PLUS SORAFENIB AS A TREATMENT OPTION FOR HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
    Saliba, F.
    Younes, A.
    Nitta, H.
    Karam, V.
    Sobesky, R.
    Vibert, E.
    Coilly, A.
    Antonini, T.
    Cherqui, D.
    Baba, H.
    Adam, R.
    Samuel, D.
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 17 - 17
  • [8] Everolimus plus Sorafenib as a treatment option for hepatocellular carcinoma recurrence after liver transplantation
    Saliba, Faouzi
    Nitta, Hidetoshi
    Younes, Aline
    Karam, Vincent H.
    Sobesky, Rodolphe
    Vibert, Eric
    Coilly, Audrey
    Antonini, Theresa
    Cherqui, Daniel
    Adam, Rene
    Samuel, Didier
    [J]. HEPATOLOGY, 2017, 66 : 901A - 902A
  • [9] A CASE REPORT: VERY LATE RECURRENCE OF RIB METASTASES OF HEPATOCELLULAR CARCINOMA (HCC) AFTER LIVER TRANSPLANTATION
    Fanchini, Laura
    Racca, Patrizia
    Ritorto, Giuliana
    Spadi, Rosella
    Milanesi, Enrica
    Zanini, Marcello
    Pinta, Francesco
    Evangelista, Walter
    Ciuffreda, Libero
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [10] Sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation
    Feun, L. G.
    Levi, D.
    Moon, J.
    Nishida, S.
    Island, E.
    Selvaggi, G.
    Martin, P.
    Savaraj, N.
    Mendes, F.
    Tzakis, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)